ENTOLI LTD
Company number 13117419 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ENTOLI LTD - Analysis Report
Company Number: 13117419
Analysis Date: 2025-07-20 14:21 UTC
Financial Health Assessment for ENTOLI LTD (As at 31 March 2024)
1. Financial Health Score: D
Explanation:
ENTOLI LTD exhibits several concerning signs in its financial "vital signs" that indicate distress. While the company maintains some liquidity with cash on hand, it has moved into a net liability position (negative net assets). This suggests its total liabilities exceed its total assets, a symptom akin to a patient showing signs of organ stress. The deterioration from positive net assets in prior years to negative signals financial strain, warranting a cautious outlook.
2. Key Vital Signs: Critical Metrics & Their Interpretation
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Current Assets | £18,806 | Decreased from prior years, indicating less short-term asset coverage. |
| Cash at Bank | £16,535 | Healthy cash reserves but declined from £21,102 in 2023, reducing buffer for operations. |
| Debtors | £2,271 | Stable but relatively small, indicating limited receivables. |
| Current Liabilities | £24,000 | Constant at £24k, exceeding current assets, indicating short-term liquidity pressure. |
| Net Current Assets (Working Capital) | £16,829 | Reported as positive but this appears inconsistent with current assets and liabilities figures; likely includes long-term creditors. Needs clarification. |
| Creditors (Non-Current Liabilities) | £24,000 | Significant long-term liabilities affecting solvency. |
| Net Assets (Total Equity) | -£7,171 | Negative net assets showing that liabilities exceed assets; symptom of financial distress. |
| Shareholders’ Funds | -£17,171 | Indicates accumulated losses beyond initial capital, weakening the financial foundation. |
| Stock | £0 (down from £8,700 in 2023) | Inventory fully depleted, possibly reflecting operational changes or asset write-downs. |
3. Diagnosis: What the Financial Data Reveals
Liquidity Status: The company holds a reasonably stable cash position (£16,535), which is crucial for meeting immediate financial obligations. However, a decline in cash compared to previous years is a symptom of tightening cash flow.
Working Capital & Short-Term Health: Although net current assets are reported as positive (£16,829), this seems inconsistent with the sum of current assets (£18,806) minus current liabilities (£24,000), which would imply a negative working capital (~ -£5,194). This discrepancy likely arises from classification of creditors or accounting presentation and should be clarified. If truly negative, this signals a liquidity crunch—akin to a patient with low blood pressure requiring urgent intervention.
Solvency & Balance Sheet Strength: The company’s net assets have turned negative (-£7,171), compared to positive equity in prior years. This indicates accumulated losses have eroded shareholder funds, a critical symptom of financial distress that threatens the company’s long-term viability.
Stock Position: The elimination of stock from £8,700 to £0 might indicate asset liquidation or changes in business operations. This could be a deliberate move to improve liquidity or a sign of reduced operational scale.
Revenue & Profitability: The absence of a profit and loss account in the filed accounts limits insight into operational performance. However, accumulated losses in reserves suggest ongoing or recent periods of unprofitability.
Directors & Control: The company is managed by three directors with relevant IT and engineering experience. Control is shared with Brandon Group Limited holding 25-50% shares and voting rights, indicating some external influence and possibly support.
4. Recommendations: Specific Actions to Improve Financial Wellness
Clarify Working Capital Position: Verify the classification and maturity of liabilities and assets to ensure accurate understanding of liquidity. This is like performing a detailed blood test to pinpoint abnormalities.
Improve Cash Flow Management: Tighten control over cash outflows and seek to accelerate receivables. Consider short-term financing or credit facilities to buffer operational cash needs.
Restructure Debt: Negotiate with creditors, especially for the £24,000 long-term liabilities, to seek more favorable repayment terms or refinancing to alleviate solvency stress.
Operational Review: Analyze business operations to identify causes of losses. Consider cost-cutting, pricing adjustments, or revenue enhancement strategies akin to lifestyle changes prescribed for a patient to improve health.
Build Reserves: Plan for rebuilding shareholder funds through retained earnings or capital injections to restore balance sheet strength.
Regular Financial Monitoring: Implement more frequent financial reviews and projections to detect and address symptoms of financial distress early.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.